BMC Endocrine Disorders最新文献

筛选
英文 中文
Early thyroid-stimulating hormone dynamics as an independent predictor of immune-related hypothyroidism during nivolumab therapy. 早期促甲状腺激素动态作为纳武单抗治疗期间免疫相关性甲状腺功能减退的独立预测因子。
IF 3.7 3区 医学
BMC Endocrine Disorders Pub Date : 2026-11-06 DOI: 10.1186/s12902-026-02681-5
Deniz Çınaroğlu, Hüseyin Döngelli, Evrim Ataca, Zeynep Gülsüm Güç
{"title":"Early thyroid-stimulating hormone dynamics as an independent predictor of immune-related hypothyroidism during nivolumab therapy.","authors":"Deniz Çınaroğlu, Hüseyin Döngelli, Evrim Ataca, Zeynep Gülsüm Güç","doi":"10.1186/s12902-026-02681-5","DOIUrl":"10.1186/s12902-026-02681-5","url":null,"abstract":"<p><strong>Background: </strong>Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape of advanced solid tumors, yet immune-related adverse events remain a major challenge. Thyroid dysfunction is among the most frequent endocrine toxicities associated with programmed cell death-1 (PD-1) inhibitors, often evolving dynamically and remaining early immune-mediated thyroid injury. Identifying an early and reliable biomarker for immune-related hypothyroidism could improve patient monitoring and treatment safety.</p><p><strong>Methods: </strong>This retrospective, single-center cohort study included 214 adult patients with solid tumors treated with nivolumab between January 2020 and January 2025. Thyroid function tests obtained at baseline and at the first month of treatment were analyzed. Early thyroid-stimulating hormone change (ΔTSH) was defined as change from baseline, calculated as first-month TSH minus baseline TSH. The primary endpoint was the development of de-novo or deteriorated hypothyroidism. Time-to-event analyses were performed using Cox proportional hazards regression. The discriminative performance of ΔTSH was assessed using receiver operating characteristic (ROC) curve analysis, with internal validation using 2,000 bootstrap resamples.</p><p><strong>Results: </strong>During follow-up, nivolumab-related thyroid adverse events occurred in 37 patients (17.3%), with de novo or deteriorated hypothyroidism observed in 27 patients. Median time to hypothyroidism was 12 weeks (IQR: 8-24). In multivariable Cox regression, ΔTSH remained independently associated with subsequent hypothyroidism (adjusted HR per 1 mU/L increase: 1.060; 95% CI: 1.036-1.085; p < 0.001), together with age. Exploratory ROC analysis demonstrated high apparent discrimination of ΔTSH for subsequent hypothyroidism (AUC 0.952, 95% CI 0.925-0.979). Internal validation using 2,000 bootstrap resamples showed a mean AUC of 0.952 (95% bootstrap CI: 0.922-0.976).</p><p><strong>Conclusions: </strong>Early ΔTSH was associated with subsequent immune-related hypothyroidism in this retrospective cohort. However, the modest sample size of 214 patients and the limited number of hypothyroidism events (n = 27) mean that the observed association and apparent discriminative performance should be regarded as preliminary, exploratory evidence. Bootstrap resampling does not overcome these data limitations. Larger cohorts with more outcome events are needed to confirm predictive performance before clinical application.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13741527/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149369975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uric acid-to-HDL cholesterol ratio is independently associated with prediabetes in a large multinational primary care population in Qatar: a cross-sectional study. 尿酸-高密度脂蛋白胆固醇比值与卡塔尔大型跨国初级保健人群的前驱糖尿病独立相关:一项横断面研究。
IF 3.7 3区 医学
BMC Endocrine Disorders Pub Date : 2026-10-28 DOI: 10.1186/s12902-026-02662-8
Saad Almallah, Ehab Hamed, AlAnoud Saleh AlFehaidi, Mohan Chandra Joshi
{"title":"Uric acid-to-HDL cholesterol ratio is independently associated with prediabetes in a large multinational primary care population in Qatar: a cross-sectional study.","authors":"Saad Almallah, Ehab Hamed, AlAnoud Saleh AlFehaidi, Mohan Chandra Joshi","doi":"10.1186/s12902-026-02662-8","DOIUrl":"10.1186/s12902-026-02662-8","url":null,"abstract":"<p><strong>Aim: </strong>Prediabetes is frequently underdiagnosed and carries significant cardiometabolic risk. The uric acid-to-high-density lipoprotein cholesterol ratio (UHR) has emerged as a marker of metabolic dysfunction, but its association with prediabetes in large multinational primary care populations remains poorly characterized. This study aimed to assess this association, compare UHR with its individual components, and evaluate effect modification and discriminatory performance.</p><p><strong>Methods: </strong>This retrospective cross-sectional study used anonymized electronic medical records from Primary Health Care Corporation, Qatar, between July 2021 and June 2025. Adults aged 18-60 years with available uric acid, HDL-C, and glycaemic data were included. Prediabetes was defined using American Diabetes Association glycaemic thresholds based on available fasting plasma glucose or HbA1c. Multivariable logistic regression adjusted for age, sex, BMI, and nationality-derived geographic sub-region. Interaction, sensitivity, and receiver operating characteristic analyses were performed.</p><p><strong>Results: </strong>Among 113,795 participants, 30,125 (26.5%) had prediabetes. Median UHR was higher in participants with prediabetes than controls (0.120 vs. 0.100; P < 0.001). Each 0.01-unit higher UHR was associated with higher adjusted odds of prediabetes (aOR 1.057, 95% CI 1.053-1.062), with a graded association across quartiles (Q4 vs. Q1: aOR 2.300, 95% CI 2.167-2.440). The association remained similar in missing-BMI sensitivity analyses and was stronger in women (interaction P < 0.001), with no evidence of interaction by geographic sub-region (P = 0.125). UHR showed modest discrimination (AUC 0.618), with an exploratory threshold of approximately 0.106.</p><p><strong>Conclusion: </strong>UHR was independently associated with prediabetes across a large multinational primary care population. However, discrimination was modest and the exploratory threshold requires external prospective validation before any clinical implementation.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13737932/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149340789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combined residual inflammation and anemia in relation to kidney function among adults with diabetes: a CHARLS-based cross-sectional and longitudinal study. 成人糖尿病患者合并残余炎症和贫血与肾功能的关系:一项基于charls的横断面和纵向研究
IF 3.7 3区 医学
BMC Endocrine Disorders Pub Date : 2026-10-23 DOI: 10.1186/s12902-026-02577-4
Wenhao Yang, Jinkui Zhao, Mingyan Yu, Qianyu Li, Rui Li, Xihai Gao, Changyong Lin, Zihan Zhai, Xiao Huang, Bo Wu
{"title":"Combined residual inflammation and anemia in relation to kidney function among adults with diabetes: a CHARLS-based cross-sectional and longitudinal study.","authors":"Wenhao Yang, Jinkui Zhao, Mingyan Yu, Qianyu Li, Rui Li, Xihai Gao, Changyong Lin, Zihan Zhai, Xiao Huang, Bo Wu","doi":"10.1186/s12902-026-02577-4","DOIUrl":"10.1186/s12902-026-02577-4","url":null,"abstract":"<p><strong>Background: </strong>The combined phenotype of residual inflammation and anemia on kidney function in diabetes remains unclear. Our study examined their joint association with impaired kidney function and kidney function decline in a nationally representative Chinese sample.</p><p><strong>Methods: </strong>Our study encompassed 2,363 diabetes patients from the China Health and Retirement Longitudinal Study (CHARLS) for cross-sectional analysis and a sub-cohort of 547 patients for longitudinal analysis (2011-2015). Exposures comprised residual inflammation (hs-CRP ≥ 2.0 mg/L) and WHO-defined anemia. Outcomes were prevalent impaired kidney function in the cross-sectional analysis and rapid kidney function decline (RKFD) in the longitudinal analysis. Logistic and linear regression, restricted cubic splines, and subgroup and sensitivity analyses were applied.</p><p><strong>Results: </strong>Cross-sectionally, isolated residual inflammation or isolated anemia were each associated with impaired kidney function, while the combined phenotype showed the strongest association (OR = 3.61, 95% CI: 2.16-5.99; P < 0.001). Longitudinally, this combined phenotype conferred the highest risk for RKFD (OR = 6.42, 95% CI: 2.18-18.34; P < 0.001) and was the only group associated with a steeper eGFR decline (β=-8.68 mL/min/1.73 m², 95% CI: -15.72 to -1.64; P = 0.011). Sensitivity analyses and RCS models supported the robustness of these associations.</p><p><strong>Conclusion: </strong>Coexisting residual inflammation and anemia are associated with a higher prevalence of kidney function impairment and a more rapid kidney function decline among diabetic patients. Addressing both conditions concurrently as an integrated clinical phenotype may better mitigate kidney function decline.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13732995/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations of anthropometric indices with all-cause and cause-specific mortality among US adults with a self-reported history of cancer: a population-based cohort study. 在自我报告有癌症病史的美国成年人中,人体测量指数与全因和病因特异性死亡率的关联:一项基于人群的队列研究
IF 3.7 3区 医学
BMC Endocrine Disorders Pub Date : 2026-10-15 DOI: 10.1186/s12902-026-02652-w
Yaxin Li, Peinan Liu, Haoyu Zhu, Danni Zhao, Chuchen Zhao, Xiaobin Ma, Meng Wang, Shuai Lin, Guochao Mao, Huafeng Kang
{"title":"Associations of anthropometric indices with all-cause and cause-specific mortality among US adults with a self-reported history of cancer: a population-based cohort study.","authors":"Yaxin Li, Peinan Liu, Haoyu Zhu, Danni Zhao, Chuchen Zhao, Xiaobin Ma, Meng Wang, Shuai Lin, Guochao Mao, Huafeng Kang","doi":"10.1186/s12902-026-02652-w","DOIUrl":"10.1186/s12902-026-02652-w","url":null,"abstract":"<p><strong>Background: </strong>Obesity is a well-established risk factor for cancer incidence and mortality. Body mass index (BMI) does not adequately characterize body shape or fat distribution. Whether a body shape index (ABSI) and body roundness index (BRI) are associated with mortality among adults with a history of cancer remains uncertain.</p><p><strong>Methods: </strong>We analyzed 3,230 NHANES participants (2003-2018) using survey-weighted Cox models adjusted for sociodemographic, behavioral, and cancer-related factors. Nonlinear and sensitivity analyses were performed.</p><p><strong>Results: </strong>During a survey-weighted median potential follow-up of 7.9 years, 937 all-cause, 315 cancer, and 197 CVD deaths occurred. In the primary model, each 1-SD higher ABSI was associated with all-cause mortality (HR 1.24, 95% CI 1.11-1.38) and CVD mortality (HR 1.55, 95% CI 1.26-1.90), but not cancer mortality (HR 1.12, 95% CI 0.96-1.29). Continuous BRI and BMI were not independently associated with the outcomes. Underweight BMI was associated with higher all-cause mortality (HR 2.44, 95% CI 1.46-4.08). BMI had a nonlinear association with all-cause mortality (P for nonlinearity = 0.002). ABSI findings remained similar across sensitivity analyses.</p><p><strong>Conclusion: </strong>Higher ABSI was associated with higher all-cause and CVD mortality among U.S. adults with a self-reported history of cancer. Further studies are needed to confirm these associations.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13725999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between platelet-to-high-density lipoprotein cholesterol ratio and incident diabetes risk: a national representative cohort study based on CHARLS. 血小板与高密度脂蛋白胆固醇比值与糖尿病发病风险的关系:一项基于CHARLS的全国代表性队列研究
IF 3.7 3区 医学
BMC Endocrine Disorders Pub Date : 2026-10-12 DOI: 10.1186/s12902-026-02627-x
Lizhu Chen, Chengpeng He, Xiaolu Chen
{"title":"Association between platelet-to-high-density lipoprotein cholesterol ratio and incident diabetes risk: a national representative cohort study based on CHARLS.","authors":"Lizhu Chen, Chengpeng He, Xiaolu Chen","doi":"10.1186/s12902-026-02627-x","DOIUrl":"10.1186/s12902-026-02627-x","url":null,"abstract":"<p><strong>Background: </strong>Diabetes mellitus has become a major global public health burden, particularly in China. The platelet-to-high-density lipoprotein cholesterol ratio (PHR) has emerged as a novel inflammatory and metabolic biomarker associated with cardiometabolic risk. However, prospective evidence regarding its association with incident diabetes remains limited. This study aimed to investigate the association between PHR and the risk of incident diabetes among Chinese middle-aged and older adults.</p><p><strong>Methods: </strong>This prospective cohort study used data from the China Health and Retirement Longitudinal Study (CHARLS) spanning from 2011 to 2020. A total of 5835 participants without diabetes at baseline (2011-2012) were included and followed up in 2013, 2015, 2018, and 2020. Participants were divided into four groups according to PHR quartiles. Kaplan-Meier survival analysis and Cox proportional hazards regression models were employed to evaluate the association between PHR and incident diabetes. Restricted cubic spline (RCS) regression was performed to explore potential linear and non-linear relationships. Subgroup and sensitivity analyses were conducted to assess the robustness of the findings.</p><p><strong>Results: </strong>During a median follow-up of 116 months, 669 participants developed incident diabetes. Kaplan-Meier analysis revealed a significantly higher cumulative incidence of diabetes in higher PHR quartiles (log-rank p < 0.001). After multivariable adjustment, Cox regression showed that participants in the highest PHR quartile (Q4) had a significantly increased risk of diabetes compared with those in the lowest quartile (Q1) (adjusted hazard ratio (HR) = 1.41, 95% confidence interval (CI): 1.11-1.78, p = 0.004). RCS analysis indicated a positive linear relationship between PHR and diabetes risk (P for nonlinearity = 0.339). Subgroup analyses showed that the association was generally consistent across most subgroups. Sensitivity analyses, including use of a composite diabetes definition (Q4 vs Q1: HR = 1.30, 95% CI: 1.09-1.56) and multiple imputation, yielded consistent findings.</p><p><strong>Conclusions: </strong>Elevated PHR levels were associated with an increased risk of incident diabetes among Chinese middle-aged and older adults. Component-specific analyses suggested that this association may be driven predominantly by HDL-C. PHR may represent a simple and routinely available candidate biomarker associated with incident diabetes risk; however, whether it provides information beyond HDL-C alone requires further investigation.</p><p><strong>Clinical trial registration: </strong>Not applicable.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13733031/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Levothyroxine dose requirements, oral bioavailability and gut microbiome enterotype dynamics during the early post-bariatric period: a single-centre, prospective, cohort study. 减重后早期左旋甲状腺素剂量需求、口服生物利用度和肠道微生物组肠型动力学:一项单中心、前瞻性队列研究
IF 3.7 3区 医学
BMC Endocrine Disorders Pub Date : 2026-10-12 DOI: 10.1186/s12902-026-02599-y
Amr Ali Mohamed Abdelgawwad El-Sehrawy, Mohammed Ali Gameil, Ahmed Mohamed El Nakib, Abdullah A Aseeri, Mansuor A Alanazi, Saud S Alharbi, Ahmed Taki-Eldin, Marwah Suliman Maashi, Gehad Mohsen ELmazny, Husam Almansour, Rufaida Abdalla, Ismail Kandil
{"title":"Levothyroxine dose requirements, oral bioavailability and gut microbiome enterotype dynamics during the early post-bariatric period: a single-centre, prospective, cohort study.","authors":"Amr Ali Mohamed Abdelgawwad El-Sehrawy, Mohammed Ali Gameil, Ahmed Mohamed El Nakib, Abdullah A Aseeri, Mansuor A Alanazi, Saud S Alharbi, Ahmed Taki-Eldin, Marwah Suliman Maashi, Gehad Mohsen ELmazny, Husam Almansour, Rufaida Abdalla, Ismail Kandil","doi":"10.1186/s12902-026-02599-y","DOIUrl":"https://doi.org/10.1186/s12902-026-02599-y","url":null,"abstract":"<p><strong>Background: </strong>Bariatric surgery induces profound metabolic changes; however, its impact on levothyroxine (LT4) requirements, hormone pharmacokinetics, and gut microbiome composition remains incompletely understood. The current study is aimed to evaluate longitudinal changes in metabolic parameters, LT4 dose requirements, free thyroxin (FT4) absorption (AUC₀-₆h), and gut microbiome features following Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG).</p><p><strong>Methods: </strong>In this prospective cohort study, 79 patients with hypothyroidism undergoing bariatric surgery (RYGB n = 40; SG n = 39) were followed at baseline, 3 month, and 6 months postoperatively. Metabolic parameters, thyroid function, LT4 dose, FT4 AUC₀-₆h, and gut microbiome diversity were assessed using linear mixed-effects models.</p><p><strong>Results: </strong>Both groups showed significant metabolic improvement at 6 months, including reductions in body mass index (RYGB: 44.5 → 32.1 kg/m²; SG: 42.9 → 33.0 kg/m², p < 0.001) and fasting blood sugar (RYGB: 114.8 → 92.4 mg/dL; SG: 109.9 → 96.1 mg/dL, p < 0.001). LT4 requirements increased significantly, particularly in RYGB (137.5 → 158.2 µg/day; p = 0.018) and SG (133.3 → 144.8 µg/day; p = 0.067), with a stronger effect in weight-adjusted dose (both p < 0.05). FT4 AUC₀-₆h increased significantly after surgery (RYGB: +330 ± 210, p = 0.003; SG: +185 ± 190, p = 0.041), indicating altered LT4 pharmacokinetics. Gut microbiome analysis revealed increased Shannon diversity (RYGB p-trend = 0.048) and significant enrichment of Akkermansia muciniphila (1.20% → 2.40%, p < 0.001), particularly in RYGB. After false discovery rate (FDR) adjustment, the major longitudinal changes remained significant, particularly for metabolic parameters, LT4 dose (µg/kg/day), and Akkermansia muciniphila in the RYGB group. Patient-level analyses showed a modest positive association between changes in A. muciniphila abundance and FT4 AUC₀-₆h after multivariable adjustment, whereas other microbiome-LT4 associations were not significant.</p><p><strong>Conclusion: </strong>Bariatric surgery was associated with substantial metabolic improvement, increased LT4 requirements, increased systemic FT4 exposure, and changes in gut microbiome composition. The observed microbiome-LT4 association was modest and should be considered exploratory and hypothesis-generating rather than causal. These findings highlight the need for individualized thyroid function monitoring and LT4 dose adjustment during the postoperative period.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13660153/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149179499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum melatonin levels and their relationship with inflammation and oxidative stress in patients with diabetic nephropathy: a cross-sectional case-control study. 糖尿病肾病患者血清褪黑素水平及其与炎症和氧化应激的关系:一项横断面病例对照研究
IF 3.7 3区 医学
BMC Endocrine Disorders Pub Date : 2026-10-07 DOI: 10.1186/s12902-026-02634-y
Emel Tatlı, Tuğba Kip
{"title":"Serum melatonin levels and their relationship with inflammation and oxidative stress in patients with diabetic nephropathy: a cross-sectional case-control study.","authors":"Emel Tatlı, Tuğba Kip","doi":"10.1186/s12902-026-02634-y","DOIUrl":"10.1186/s12902-026-02634-y","url":null,"abstract":"<p><strong>Background: </strong>Diabetic nephropathy (DN), a major microvascular complication of type 2 diabetes mellitus (T2DM), is driven by oxidative stress and chronic inflammation. Melatonin, an endogenous indoleamine with potent antioxidant and anti-inflammatory properties, has been implicated in diabetic complications but its relationship with systemic inflammation and oxidative balance in DN remains incompletely characterised. This study aimed to evaluate serum melatonin levels in T2DM patients with and without nephropathy compared with healthy controls, and to assess associations with inflammatory indices (C-reactive protein, CRP; neutrophil-to-lymphocyte ratio, NLR) and total antioxidant/oxidant status (total antioxidant status, TAS; total oxidant status, TOS).</p><p><strong>Methods: </strong>This cross-sectional case-control study included 83 participants: 59 patients with T2DM (29 with DN and 30 without DN) and 24 healthy controls. Serum melatonin was measured by a validated enzyme-linked immunosorbent assay (ELISA). TAS and TOS were measured by an automated colorimetric method (Erel method). Inflammatory indices and renal-function markers were measured by standard methods. Receiver operating characteristic (ROC) curve analysis and multivariate logistic regression were used to evaluate predictive performance for DN.</p><p><strong>Results: </strong>Serum melatonin was significantly lower in T2DM patients than controls (22.00 ± 15.56 vs. 42.88 ± 29.61 ng/L, p < 0.001), accompanied by reduced TAS (4.05 ± 3.94 vs. 7.87 ± 6.68 mmol/L, p < 0.001) and TOS (2.33 ± 2.43 vs. 8.50 ± 11.77 µmol/L, p = 0.002), and markedly elevated CRP (p < 0.001). Within the diabetic cohort, neither TAS nor TOS differed significantly between DN and non-DN patients; serum melatonin was paradoxically marginally higher in the DN group (p = 0.043), in the opposite direction to the conventionally hypothesised pattern. In contrast, DN patients had markedly higher urea and creatinine, lower albumin, and higher CRP (p = 0.008). Melatonin correlated strongly and positively with TAS (ρ = 0.83) and TOS (ρ = 0.75). Urea provided the strongest discrimination for DN among the markers assessed (area under the curve, AUC, 0.805, 95% confidence interval, CI, 0.696-0.897), followed by estimated glomerular filtration rate (eGFR) (AUC 0.737); melatonin discriminated DN only modestly (AUC 0.666).</p><p><strong>Conclusions: </strong>Serum melatonin and total antioxidant capacity are concurrently reduced in T2DM, reflecting a coupled deficit of antioxidant defence. However, melatonin and TAS/TOS did not independently distinguish DN from non-DN diabetic patients; conventional renal-function markers and CRP were the dominant correlates of nephropathy. Melatonin appears to mark the global oxidative-metabolic burden of T2DM rather than nephropathy specifically.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13647695/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149134567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Occupational cadmium exposure and endocrine biomarker alterations in male workers: a cross-sectional study. 男性工人职业性镉暴露与内分泌生物标志物改变:一项横断面研究。
IF 3.7 3区 医学
BMC Endocrine Disorders Pub Date : 2026-09-28 DOI: 10.1186/s12902-026-02605-3
Deniz Özkan Vardar, Lütfiye Tutkun, Servet Birgin İritaş, Melih Gaffar Gözükara, Gülsüm Abuşoğlu, Serdar Deniz, Vugar Ali Türksoy, Engin Tutkun
{"title":"Occupational cadmium exposure and endocrine biomarker alterations in male workers: a cross-sectional study.","authors":"Deniz Özkan Vardar, Lütfiye Tutkun, Servet Birgin İritaş, Melih Gaffar Gözükara, Gülsüm Abuşoğlu, Serdar Deniz, Vugar Ali Türksoy, Engin Tutkun","doi":"10.1186/s12902-026-02605-3","DOIUrl":"https://doi.org/10.1186/s12902-026-02605-3","url":null,"abstract":"<p><strong>Background: </strong>Occupational exposure to cadmium (Cd) remains an important environmental health concern, particularly in industrial settings where long-term exposure may affect multiple physiological systems. Although Cd has been linked to reproductive and cardiovascular toxicity, human studies that simultaneously evaluate biomarkers of endocrine and endothelial dysfunction remain limited. This cross-sectional study examined the association between occupational Cd exposure and hormonal and endothelial biomarkers in adult male workers.</p><p><strong>Methods: </strong>This cross-sectional study included 170 men, comprising 85 cadmium-exposed workers and 85 unexposed controls. Urinary cadmium concentrations were measured by inductively coupled plasma mass spectrometry (ICP-MS). Serum levels of total testosterone, luteinizing hormone (LH), follicle-stimulating hormone (FSH), asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), arginine, and citrulline were measured using standard laboratory methods. Group comparisons and correlation analyses were conducted to assess associations between cadmium exposure and biomarker profiles.</p><p><strong>Results: </strong>Cadmium-exposed workers had substantially higher urinary Cd concentrations than controls and higher ADMA and SDMA levels (both p < 0.001). In contrast, total testosterone, FSH, and the arginine/ADMA ratio were significantly lower in the exposed group, while LH showed a smaller but statistically significant reduction. Urinary Cd was inversely correlated with total testosterone and FSH, indicating that a higher internal cadmium burden was associated with less favorable endocrine biomarker profiles.</p><p><strong>Conclusions: </strong>Occupational cadmium exposure was associated with concurrent changes in endocrine and endothelial biomarkers among male workers. These findings suggest that combined assessment of endocrine and endothelial biomarkers may be useful for occupational monitoring of workers with chronic cadmium exposure.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13625303/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149104007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hair cortisol as a complementary marker of chronic glucocorticoid exposure in mild autonomous cortisol secretion. 毛发皮质醇作为轻度自主皮质醇分泌的慢性糖皮质激素暴露的补充标志物。
IF 3.7 3区 医学
BMC Endocrine Disorders Pub Date : 2026-09-28 DOI: 10.1186/s12902-026-02607-1
Merve Korkmaz Yilmaz, Semih Tek, Aslihan Pekmezci, Mutlu Niyazoglu, Esra Hatipoglu
{"title":"Hair cortisol as a complementary marker of chronic glucocorticoid exposure in mild autonomous cortisol secretion.","authors":"Merve Korkmaz Yilmaz, Semih Tek, Aslihan Pekmezci, Mutlu Niyazoglu, Esra Hatipoglu","doi":"10.1186/s12902-026-02607-1","DOIUrl":"10.1186/s12902-026-02607-1","url":null,"abstract":"<p><strong>Background: </strong>Mild autonomous cortisol secretion is a subtle yet clinically relevant form of cortisol excess linked to increased cardiometabolic risk. Conventional biochemical tests capture short-term hypothalamic-pituitary-adrenal axis activity and may not reflect cumulative exposure. Hair cortisol concentration has been proposed as a long-term biomarker, but evidence in mild autonomous cortisol secretion is limited.</p><p><strong>Objective: </strong>To compare hair cortisol concentration between patients with mild autonomous cortisol secretion and healthy controls, assess diagnostic performance, and examine associations with hormonal and metabolic parameters.</p><p><strong>Methods: </strong>In this cross-sectional study, 73 patients with mild autonomous cortisol secretion and 60 rigorously screened controls were included. Mild autonomous cortisol secretion was defined according to European Society of Endocrinology guidelines. Hair cortisol concentration was measured from the proximal 3-cm hair segment. Assessments included the 1-mg overnight dexamethasone suppression test, 2-day 2 mg dexamethasone suppression test, 24-hour urinary free cortisol, and late-night salivary cortisol. Correlation and receiver operating characteristic analyses were performed.</p><p><strong>Results: </strong>Hair cortisol concentration was significantly higher in patients with mild autonomous cortisol secretion than in controls (median 3.6 vs. 1.75 ng/g; p < 0.01). In patients with mild autonomous cortisol secretion, hair cortisol concentration correlated with waist circumference (ρ = 0.27; p = 0.02) and late-night salivary cortisol (ρ = 0.25; p = 0.03), but not with dexamethasone suppression test-based measures or urinary cortisol. Receiver operating characteristic analysis showed modest discrimination (AUC = 0.60, 95% CI 0.51-0.70, p = 0.025); the 2.7-ng/g cut-off yielded limited sensitivity and specificity. In multivariable logistic regression adjusted for age, sex, and body mass index, hair cortisol concentration was not independently associated with mild autonomous cortisol secretion.</p><p><strong>Conclusions: </strong>Hair cortisol concentrations were higher in patients with mild autonomous cortisol secretion than in healthy controls, suggesting that hair cortisol concentration may capture some aspects of chronic glucocorticoid exposure in this population. However, its diagnostic performance was modest, and hair cortisol concentration was not independently associated with mild autonomous cortisol secretion after adjustment for age, sex, and body mass index. Therefore, hair cortisol concentration should be regarded as a complementary rather than a standalone biomarker, and further prospective studies are needed to clarify its clinical utility.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13678971/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149223440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum long noncoding RNA human plasmacytoma variant translocation 1 (PVT1) expression levels in Egyptians type 2 diabetic patients and its correlation with severity of diabetic nephropathy. 埃及2型糖尿病患者血清长链非编码RNA人浆细胞瘤变异易位1 (PVT1)表达水平及其与糖尿病肾病严重程度的相关性
IF 3.7 3区 医学
BMC Endocrine Disorders Pub Date : 2026-09-17 DOI: 10.1186/s12902-026-02449-x
Aya Tarabay, Olfat Gamil Shaker, Naglaa M ElSayed, Dina Allam, Abeer Abdellatef, Mazen Attia
{"title":"Serum long noncoding RNA human plasmacytoma variant translocation 1 (PVT1) expression levels in Egyptians type 2 diabetic patients and its correlation with severity of diabetic nephropathy.","authors":"Aya Tarabay, Olfat Gamil Shaker, Naglaa M ElSayed, Dina Allam, Abeer Abdellatef, Mazen Attia","doi":"10.1186/s12902-026-02449-x","DOIUrl":"10.1186/s12902-026-02449-x","url":null,"abstract":"<p><strong>Background: </strong>Continuous rise in the global incidence of type 2 diabetes mellitus (T2DM) has been associated with a marked increase in diabetic kidney disease (DKD). Despite that, the clinical markers that are currently used for diagnosing diabetic nephropathy (DN) still not reliable. In recent years, long non-coding RNAs (lncRNAs) have drawn growing attention, with accumulating evidence linking their dysregulated expression to the onset and progression of DKD.</p><p><strong>Aim of the study: </strong>This study aimed to assess serum lncRNA PVT1 expression in Egyptian patients with type 2 diabetes mellitus and evaluate its association with the progression and severity of diabetic kidney disease.</p><p><strong>Patients and methods: </strong>A total of 80 adults were enrolled and divided into four groups (20 each): three type 2 diabetes mellitus groups stratified by urinary albumin-to-creatinine ratio (UACR; normal, moderately increased, and severely increased) and one healthy control group. Diabetic patients were further classified by fundus examination into those with and without retinopathy. All participants underwent clinical and laboratory evaluation, and serum lncRNA PVT1 expression was quantified using real-time PCR.</p><p><strong>Results: </strong>Serum lncRNA PVT1 expression was markedly elevated in patients with type 2 diabetes compared to healthy controls, with significantly higher levels observed in G3 relative to G1. A significant positive correlation was found between PVT1 expression and UACR, serum creatinine, age, BMI, fasting blood glucose, 2-hour postprandial glucose, and HbA1c. Conversely, PVT1 demonstrated a significant negative correlation with eGFR, ALT, and platelet count. Notably, PVT1 emerged as the sole independent predictor of proteinuria among diabetic patients.</p><p><strong>Conclusion: </strong>lncRNA PVT1 is significantly overexpressed in T2DM patients and correlates with glycemic status and renal dysfunction. It serves as a potential reliable biomarker for DKD severity and progression and represents a potential therapeutic target.</p><p><strong>Clinical trial number: </strong>Not applicable.</p>","PeriodicalId":9152,"journal":{"name":"BMC Endocrine Disorders","volume":"26 1","pages":""},"PeriodicalIF":3.7,"publicationDate":"2026-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13587462/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149001264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书